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ABSTRACT
Objectives: Recurrent pregnancy loss (RPL) is a heterogeneous condition consisting of three or more consecutive abor-
tions before the 20 weeks of gestation. The tumor necrosis factor alpha (TNF-α) gene plays a crucial role in immunology 
and inflammation responses. Interleukin 1 receptor antagonist (IL-1RN) is an important anti-inflammatory molecule which 
plays important roles in pregnancy. The aim of this study was to investigate effects of TNF-α and IL-1Ra polymorphisms 
on RPL in Azari women.
Material and methods: The study participants consisted of 100 women with RPL from Iranian Azeri Turkish origin. The 
control group comprised 100 age and ethnically matched healthy women in the reproductive age. Genomic DNA was 
extracted from the whole blood and genotype determinations were performed using PCR amplification followed by restric-
tion fragment length polymorphism (RFLP) analysis.
Results: No significant association was indicated between IL-1Ra and RPL among Iranian Azeri Turkish women. Unlike the 
homozygous state, significantly higher frequency of -857 C/T variant was seen in RPL patients than control subjects. Sig-
nificantly lower frequency of wild type genotype was observed in RPL patients than of controls. Any association was found 
between the other TNF-α polymorphisms and RPL.
Conclusions: TNF-α -857 C/C variant might represent protective effect against RPL and the -857 C/T variant might be a ge-
netic risk factor for the occurrence of RPL. Invariant differences in the prevalence of -511 C/T and -31 C/T polymorphisms 
and IL-1RN VNTR between RPL patients.
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INTRODUCTION 
Recurrent pregnancy loss (RPL) is a multifactorial event 
consisting of three or more consecutive abortions before 
20 weeks of gestation [1] which occurs in approximately 
1–2% of women at the reproductive age [2]. The causes 
are very heterogeneous including genetic, anatomical, 
chromosomal and endocrinological factors. In addition, 
environmental factors such as exposure to ethylene ox-
ide and lead have been considered [3]. In some cases, RPL 
arises from immunologic problems [4] and coagulation 
factors mutations [5]. Furthermore, hyperprolactinemia and 
hyperhomocysteinuria [6] as well as infectious agents [7] 
have been identified. However, it has been proven that the 
reason is unknown for approximately 40–50% of patients [8]. 
According to these heterogeneous causes, the appropriate 
evaluation of patients is necessary to explore the exact un-
derlying pathophysiologic mechanisms; thereby the cases 
experiencing this event would receive a better treatment [6].
It is obvious that T helper 1 (Th1) and T helper 2 (Th2) 
are the major components of immune system and their 
functional balance has great importance for a normal preg-
nancy [9]. Th2 type cytokines including Il-4, IL-5, IL-6 and 
IL-10 are involved in normal pregnancy. In contrast, Th1 pro-
duces proinflammatory cytokines containing IL-1, IFN-γ 
and TNF-α which are supposed to be related to poor preg-
nancy outcome [10]. Tumor necrosis factor alpha (TNF-α) 
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is an important proinflammatory cytokine secreted by 
monocytes/macrophages, B cells, natural killer (NK) cells 
and antigen-stimulated T cells which is located in 6p21.3, 
the region of human leukocyte antigen (HLA) class III [1]. 
It has been described that this cytokine is effective on the 
process of RPL [11]. TNF-α production, secretion and activ-
ity are influenced by eight polymorphisms which occur in 
the promoter region as follows: 1031T/C, 863C/A, 857C/T, 
575G/A, 376G/A, 308G/A, 244G/A, and 238G/A (1). There are 
conflicting reports about the association of these polymor-
phisms and RPL in different population. In this regard, some 
literature showed a positive association [12], but a negative 
relationship was reported by others [13]. The presence of six 
TNF-α polymorphisms at the positions -1031T/C, -863C/A, 
-857C/T, -376G/A, -308G/A and -238G/A were compared 
in the present study to make a better decision about the 
association of TNF-α polymorphisms in RPL. 
IL-1 family has an important role in inflammatory re-
actions. The IL-1 gene cluster has located within 430 kb 
region on chromosome 2 (2q13-21) [14]. Two types of cy-
tokines constitute the family: pro-inflammatory cytokines 
(IL-1α, IL-1β) and an anti-inflammatory substance the 
IL-1 receptor antagonist (IL-1Ra or IL-1RN) [14]. The hu-
man IL-1RN gene has been determined on the band 
q14-q21 in which intron 2 encompasses variable number 
tandem repeat (VNTR) polymorphism with an 86-base pair, 
and the VNTR sequence is repeated 2 to 6 times. Gener-
ally, there are 4, 2, 5, 3 and 6 repeats in allele 1 (IL-1RN*1), 
allele  2 (IL-1RN*2), allele 3 (IL-1RN*3), allele 4 (IL-1RN*4) 
and allele 5 (IL-1RN*5), respectively [15]. The production of 
IL-1RN gene is a 16–18 kDa protein which prohibits the ac-
tion of IL-1 as a competitive inhibitor and induces no signal 
transduction [14]. As an anti-inflammatory event takes place 
over a normal pregnancy, the levels of IL-1RN would be 
raised and an inflammation reaction can be terminated [16]. 
Individual susceptibility to disease would be determined 
by the levels of cytokines production which is affected by 
cytokine gene polymorphisms [17]. It has been suggested 
that IL-1 plays a crucial role in embryonic development 
through the regulation of blastocyst implantation and the 
inducement of the endometrial leukemia inhibitory factor 
(LIF) production. Moreover, gene expression and synthesis 
of IL-1RN have been established in the dividing embryo [18], 
which is considered to be associated with RPL [15]. 
To our knowledge, there have been no reports on the 
frequency of these in the TNF-α and IL-1Ra gene and their 
relationship with RPL in Iranian population. Furthermore, 
conflicting findings have been mentioned in different stud-
ies. Hence, to shed new insight on the mechanisms of the 
RPL, allele frequencies and genotype distributions of TNF-α 
and IL-1Ra gene polymorphisms and their association with 
RPL were investigated in cases and the results were com-
pared with those of the age and ethnically matched healthy 
fertile subjects from Iranian Azeri Turkish population.
MATERIAL AND METHODS
A case-control study was conducted to determine the 
association of RPL with IL-1RN VNTR and TNF-α (-1031T/C, 
-863C/A, -857C/T, -376G/A, -308G/A and -238G/A) polymor-
phism. A total of 100 patients and 100 healthy controls who 
attended the educational hospitals were related to Tabriz 
University of medical sciences between 2011 and 2012. Were 
included in this retrospective case control study. Subjects 
were women aged 21–45 years who had experienced at least 
three continuous abortions before 20 weeks of conception. 
The patients’ karyotypes and the structure of uterine were 
normal, no infection related miscarriages were detected 
and any other identifiable causes were figured out. So, the 
events were classified as unexplained pregnancy loss. The 
age matched control subjects were selected from healthy 
fertile women with at least two live births and no history of 
pregnancy loss. In order to prevent the epidemiological bias, 
all recruited subjects had the same ethnicity and belonged 
to Iranian Azeri Turkish origin. All participants were informed 
about the study and signed a consent form. 
In DNA extraction stage blood samples (5 mL) from 
antecubital vein were collected into tubes containing EDTA 
as an anticoagulant. Genomic DNA was extracted using the 
proteinase K method. Nanodrop instrument was employed 
to determine the quality and quantity of each DNA sample 
and electrophoresis on the 1% agarose gel was performed to 
confirm the results. The extracted DNA samples were stored 
at -20°C until analyzed. In the following, experiments were 
conducted respectively:
 Ū TNF-α: DNA samples were amplified and investigated 
for six polymorphisms in the promoter region of TNF-α 
gene (-1031T/C, -863C/A, -857C/T, -376G/A, -308G/A and 
-238G/A) using polymerase chain reaction (PCR): 1 cycle 
of initial denaturation in 94°C for 5 minutes, followed by 
35 cycles of denaturation (94°C for 1 minutes), anneal-
ing (for 45”), extension ( 72°C for 45”) and a final exten-
sion at 72°C for 5 minutes. This protocol was used for all 
polymorphisms but the annealing temperatures for each 
pair of primers were different (Table 1). The PCR products 
were electrophoresed on 1.5% agarose gel stained by 
ethidium bromide. Following amplification reaction, the 
PCR products were digested through restriction fragment 
length polymorphism (RFLP) analysis using the appropri-
ate restriction endonucleases. Then, electrophoresis of 
the digested products was performed on 3% agarose gel 
stained by ethidium bromide. The size of bands was esti-
mated by using a 50 base pair molecular weight marker. 
A gel documentation instrument was used for visualizing 
the bands of PCR and digested products of RFLP analysis.
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 Ū IL-1RN: To amplify the second intron of the 86-bp VNTR 
containing gene of IL-1RN, DNA was amplified by polymer-
ase chain reaction (PCR): Initial denaturation for 1 minute 
at 94°C, followed by 35 cycles of denaturation (1 minute 
at 94°C), annealing (45 seconds at 55°C), extension (45 sec-
onds at 72°C), and a final extension for 5 minutes at 72°C 
using the following primers: 5’CTCAGCAACACTCCTAT3’ 
(Forward) and 5’TCCTGGTCTGCAGGTAA3’ (Reverse).
Electrophoresis was performed on 1.5% agarose gel 
stained by ethidium bromide to determine the size of am-
plified PCR products. The gels were photographed by using 
the gel documentation instrument. In addition, a 50 bp size 
marker was loaded onto the gel. The chi-square test was 
used to analyze differences in the TNF-α and IL-1RN geno-
type distribution and allele frequency between the case and 
control groups (SPSS software version 20). The odds ratio 
(OR) was used as a measure of the strength of the associa-
tion between allele frequencies and RPL. All P values were 
two-tailed and 95% confidence intervals (CI) were calculated. 
P values < 0.05 were considered statistically significant.
The chi-square test was used to analyze differences in 
the genotypes distribution and allele frequency between 
the case and control groups (SPSS software version 20). 
The odds ratio (OR) was used as a measure of the strength 
of the association between allele frequencies and RPL. All 
P values were two-tailed and 95% confidence intervals (CI) 
were calculated. P values < 0.05 were considered statisti-
cally significant.
RESULTS
100 patients with at least three unexplained RPL (mean 5, 
range 3–7) and 100 age and ethnically matched controls 
who had at least two successful delivery from Iranian Azeri 
Turkish origin were screened for the TNF-α (1031T/C, 863C/A, 
857C/T, 376G/A, 308G/A, and 238G/A) and IL-1RN polymor-
phisms. The results were as follows:
TNF-α allele frequencies and genotypes distribution 
in RPL patients and control subjects are shown in (Ta-
bles  2 and  3), respectively. With exception of -857 C/T 
variant, there were no significant association between the 
genotype prevalence of TNF-α polymorphisms in the case 
and the control groups. According to TNF-α -857 variant, 
there was a lower frequency of CC genotype in RPL patients 
than that of controls which was statistically significant (45% 
vs. 63%, OR = 0.48, CI = 0.26–0.87, p = 0.01). In contrast, the 
frequency of CT genotype across the cases was significantly 
higher than controls (47% vs. 30%, OR = 2.06, CI = 1.11–3.86, 
p = 0.02). However, no significant differences were displayed 
for TNF-α -857T (mutant) allele (31.5% vs. 22%, OR = 1.63, 
CI = 1.01–2.61, p = 0.42) and homozygous (TT) genotype 
(8% vs.7%, OR = 1.15, CI = 0.36–3.78, p = 1.00) among the 
case and control groups, respectively. Hence, it seems that 
being heterozygous for TNF-α -857 variant may lead to 
an increase in susceptibility to the RPL. 
In IL-1RN the sizes of amplified alleles were 410 bp, 
240bp, 500bp, 325bp and 595 bp, respectively. No statis-
tically significant difference was observed between the 
study and control groups with respect to all genotypes. For 
instance, according to allele 1 homozygotes (IL-1 RN1/1; 
53% vs. 51%; P: 0.88; OR: 1/083; 95% CI: 0/599–1/961) and 
allele 1 heterozygotes (IL-1 RN1/2: 35% vs. 28%; P: 0.36; OR: 
1.385; 95% CI: 0/728–2/636), the dispensation of genotype 
prevalence was not significantly different in the RPL pa-
tients from the healthy subjects (Table 4). The genotype 
and allele frequencies of women experiencing RPL and 
their healthy controls and the associated ORs are shown in 
Table 5 and Table 6. As can be found from the table, there is 
no meaningful differences among the prevalence of IL-1RN 
alleles in the control group compared to cases. The most 
frequent allele in patients and controls were IL1RN*1 which 
was higher among the patients than controls. However, no 
significant difference was observed (73.5% vs. 69%; P: 0.37; 
Table 1. Primer sequences used for detection of TNF-α gene polymorphisms
Size of amplified productAnnealing temperaturePrimer sequencesPolymorphism
26455F-TATGTGATGGACTCACCAGGTR-CCTCTACATGGCCCTGTCTTTNFα -1031
12557F-GGCTCTGAGGAATGGGTTACR-CTACATGGCCCTGTCTTCGTTACGTNFα -863
12856F-GGCTCTGAGGAATGGGTTACR-CCTCTACATGGCCCTGTCTACTNFα -857
10552F-CCCCGTTTTCTCTCCCTCAAR-TGTGGTCTGTTTCCTTCTAATNFα -376
14755F-GAGGCAATAGGTTTTGAGGGCCATR-GGGACACACAAGCATCAAGTNFα -308
30964F-AAACAGACCACAGACCTGGTCR- CTCACACTCCCCATCCTCCCGGATCTNFα - 238
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OR: 1/969–0/789). On the other side, no IL1RN*5 was found 
and IL1RN*4 allelic frequency was only 0.5% in both groups.
DISCUSSION
According to the heterogeneous entity of pregnancy 
loss, different factors have been considered to be related 
with this unpleasant event including coagulation factor 
gene polymorphisms [19], HLA-G polymorphisms [20], 
anatomical problems, chromosomal abnormality [3] and 
some other reasons [6]. Several projects have involvement 
in Iran abroad polymorphisms TNF and IL-1 receptor antago-
nist gene was performed in recurrent pregnancy loss. Some 
of these studies of polymorphisms as a risk factor for recur-
rent pregnancy loss have been introduced, while some 
relationship between this polymorphism and recurrent 
miscarriage have been denied. 
Table 2. Restriction fragment length polymorphism (RFLP) analysis
Polymorphism Size of amplified fragment Restriction enzyme Genotype Size of digested fragments
-1031 T/C 264 BbsI
TT 264
TC 264-193-71
CC 193-71
-863 C/A 125 TaiI
CC 125
CA 125-104-21
AA 104-21
-857 C/T 128 TaiI
CC 109-19
CT 128-109-19
TT 128
-376 G/A 105 Tsp5091
GG 105
GA 105-83-22
AA 83-22
-308 G/A 146 NcoI
GG 125-21
GA 146-125-21
AA 146
-238 G/A 154 BamHI
GG 129-25
GA 154-129-25
AA 154
Table 3. Distribution of TNF-α genotypes among cases and control subjects
Polymorphism Genotype RPL Cases (100) Controls (100) P value OR
-1031 T/C
TT
TC
CC
71
27
2
63
33
4
0.29
0.44
0.68
1.43
0.75
0.79
-863 C/A
CC
CA
AA
72
26
2
68
27
5
0.64
1.0
0.44
1.21
0.95
0.38
-857 C/T
CC
CT
TT
45
47
8
63
30
7
0.01
0.02
1.00
0.48
2.06
1.15
-376 G/A
GG
GA
AA
99
1
0
98
2
0
1.00
1.00
1.00
2.02
0.49
-
-308 G/A
GG
GA
AA
4
84
12
9
86
5
0.25
0.84
0.12
0.42
0.85
2.59
-238 G/A
GG
GA
AA
96
4
0
97
2
1
1.00
0.68
1.00
0.74
2.04
0.00
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Table 4. TNF-α polymorphisms allele frequencies among cases and control subjects
OR
(95% CI)P-valueControls (%)Cases (%)Minor AllelePolymorphism
0/71
(0/41–1/22)0/2420/515/5C-1031 T/C
0/77
(0/44–1/36)0/4218/515A-863 C/A
1/63
(1/01–2/61)0/422231/5T-857 C/T
0/49
(0/01–7/04)1/0010/5A-376 G/A
1/27
(0/84–1/92)0/274854A-308 G/A
1/00
(0/20–4/82)1/0022A-238 G/A
Table 5. Genotype frequencies of the IL-1RN polymorphism among Iranian RPL patients and healthy fertile women 
Odds ratio (95%CI)P valueControls(n = 100)
Patients
(n = 100) Genotype IL-1RN
1/083
(0/599–1/961)0/8851 (51%)53 (53%)IL-1RN 1/1
1/385
(0/728–2/636)0/3628 (28%)35 (35%)IL-1RN 1/2
0/699
(0/185–2/568)0/767 (7%)5 (5%)IL-1RN 1/3
1/000
(0/027–37/156)1/001 (1%)1 (1%)IL-1RN1/4
0/375
(0/095–1/363)0/1610 (10%)4 (4%)IL-1RN 2/2
1/000
(0/098–10/167)1/002 (2%)2 (2%)IL-1RN 2/3
0/000
(0/000–17/447)1/001 (1%)0IL-1RN 3/3
–1/0000IL-1RN 4/4
–1/0000IL-1RN 5/5
Table 6. Allelic frequencies of the IL-1RN polymorphisms among Iranian RPL patients and healthy fertile women
Odds ratio
(95%CI) P value
Controls (%)
(n = 100)
Patients (%)
(n = 100) Allele IL-1RN
1/246
(1/969–0/789)0/376973/5IL-1RN 1
0/871
(1/4217–0/535)0/632522/5IL-1RN 2
0/623
(1/780–0/213) 0/475/53/5IL-1RN 3
1/00
(36/817–0/027)1/000/50/5IL-1RN 4
–1.0000IL-1RN 5
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It has been shown that Th1 cells play a crucial role in 
an inflammatory response and through the production of 
pro-inflammatory cytokines, IL-1, IFN-γ and TNF-α; they will 
affect the pregnancy outcome. TNF-α levels are also elevated 
in both mother and her embryo which is related with preterm 
parturition [21]. Considering the vital effect of TNF-α on preg-
nancy outcome and according to the varied reports on the 
association of different polymorphisms and the occurrence 
of RPL, we focused on six TNF-α gene polymorphisms. Zhang 
et al. also found that the -238G/A polymorphism might be 
related with the risk of recurrent spontaneous abortion [22]. 
However, there are some studies in which TNF-α -308 has 
been known to be associated with pregnancy loss [1]. In 
a study among Iranian women, no significant association 
between TNF-α -308 and RPL was observed [23]. TNF-α 
−1031T/C, −863C/A, −857C/T, −376G/A, −308G/A, −238G/A, 
and +488G/A single nucleotide polymorphisms were inves-
tigated across Bahraini Arabs by Finnan et al. Among these 
variants, −1031T/C, −376G/A, and −238G/A were concluded 
to be independently associated with recurrent miscarriage 
[24]. Based on another report, TNF-α -863 variant was not also 
related to RPL in Caucasian women [13]. Babbage et al. con-
ducted an investigation into the predisposing effect of TNF-α, 
IFN-γ and IL-10 polymorphisms on the occurrence of RPL and 
no relation were found [25]. Since various ethnic groups were 
selected in different studies, for instance, Caucasian [22], 
Iranian [23], Indian [8] or Arabs [24]; it is not illogical to relate 
the differences in the results of these studies to the effect of 
different ethnicity of study population. Besides, sample size, 
selected cases and selection criteria [26], geographic differ-
ences [19] and the other involved genes [27] might be attrib-
uted to the conflicting results. Apart from TNF-α -857 variant, 
our results were in concordance with previously mentioned 
studies. In this regard, it was found that TNF-α -857 CT geno-
type was highly associated with RPL in Iranian Azeri Turkish 
women, while no significant association was detected for 
other five polymorphisms. Thereby, it is suggested that TNF-α 
-857 C/C variant might have a protective effect against RPL, 
but the -857 C/T variant is probably a genetic risk factor for 
the occurrence of RPL. Therefore, it is suggested that for the 
future studies, the effect of -857C/T polymorphism on the 
predisposition to RPL should be considered with more atten-
tion. Finally, in the present study, an association was found 
just for TNF-α -857 gene polymorphism and no remarkable 
differences were observed for the other TNF-α variants when 
compared to normal controls. 
Moreover, several studies have been carried out to iden-
tify an association between IL-1RN polymorphisms and RPL 
in different conditions. However, due to conflicting reports, 
we decided to investigate this polymorphism in our ethnic 
population. Karthukorpi et al, reported that the frequency 
differences of IL-1RN*1 and -1RN*2 in women suffering from 
recurrent spontaneous abortion compared with healthy sub-
jects were not considerably different, while the IL-1RN*3 was 
significantly higher in patients than controls [28]. According 
to IL-1RN*1 and IL-1RN*2, the results of our investigation 
were in concordance with Karthukorpi, but it did not confirm 
their findings about IL-1RN*3. Of note, despite the higher 
frequency of allele 2 homozygotes (IL-1 RA2/2) in healthy 
subjects than patients (10% vs. 4%), its association with RPL 
were not meaningful (P: 0.16). Such a result was obtained by 
Die et al., who stated that IL-1RN*2 is not related to idiopathic 
recurrent spontaneous abortion in the Chinese Han popula-
tion [29]. Vargas-Alarcon et al. compared the prevalence of 
IL-1RN, IL-6, IL-10, INF-γ, and TNF-α gene polymorphisms and 
found a significantly different distribution of these in the 
Mexican population [30]. Linjawi et al., compared 206 women 
with recurrent miscarriage with their controls in terms of IL- 
1RN*2 alleles and found no noticeable differences between 
their frequencies [17]. Similar to Linjawi, Agrawal [31] and 
Traina [26] studies as well as Levrant et al. [15], we found no 
remarkable differences between the frequencies of IL-1RN 
polymorphisms in females experiencing RPL and their con-
trols who were Iranian Azeri Turkish women with at least two 
healthy, term infants. Likewise, such a result was obtained 
by Jaaskelainen et al. [32]. In contrast, Perni et al. explained 
an increase in spontaneous abortions in the presence of fetal 
IL-1RN*1 [33]. As has been mentioned in the literature, the 
controversial reports from different studies can be satisfied by 
various reasons: the differences in the selected study groups 
[15], divergent sample sizes [31], accidental events, other 
involved genes and the mechanisms regulating the produc-
tion of such cytokines [27] and the different environmental 
factors of the two groups [34]. It is believed that finding the 
association of gene polymorphisms and unexplained abor-
tions will provide us a better understanding about patients’ 
problem or determination of women who are at the risk of 
pregnancy loss. Furthermore, identification of gene variants 
would change the treatment strategy of the subjects [15]. 
CONCLUSIONS
In conclusion, the exact role of IL-1RN polymorphisms 
in RPL is not still fully understood. Thus, to reach the more 
accurate results and to define the specific function of IL-1RN 
polymorphisms in pregnancy loss, it is essential to repeat 
studies and design a more extensive research with a higher 
number of subjects from different ethnic origins.
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